Home NDC 0713-0915-75 Evoxac
Product NDC 0713-0915
Requested package NDC 0713-0915-75
11-digit product format 007130915
Labeler code 0713
Product ID 0713-0915_5fdb2294-e353-0887-e063-6394a90ad0a2
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name cevimeline hydrochloride
Dosage form SOLUTION
Route ORAL
Labeler Cosette Pharmaceuticals, Inc.
Application NDA221183
Marketing category NDA
Marketing start 2026-10-15
Substance CEVIMELINE HYDROCHLORIDE
Active strength 30 mg/5mL
Pharmacologic classes Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N221183-001 EVOXAC CEVIMELINE HYDROCHLORIDE 30MG/5ML SOLUTION / ORAL RLD, RS 2026-10-15
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N221183-001 12558347 2045-05-20 U-4634 Drug product 2026-10-28
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N221183-001 EVOXAC 30MG/5ML SOLUTION / ORAL RLD, RS 2026-10-15 d4dbc9d85df4…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N221183-001 12558347 2045-05-20 U-4634 Drug product 2026-10-28 d4dbc9d85df4…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Evoxac
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CEVIMELINE HYDROCHLORIDE 30 mg/5mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination P81Q6V85NP Internal UNII lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 0713-0915-75 00713091575 473 mL in 1 BOTTLE (0713-0915-75) 473 ml 2026-10-15 No No Current